Patent · US Active

Reduced size self-delivering nucleic acid compounds targeting long non-coding RNA

US11021707B2 · kind B2 · utility

5Cited by

193References

19Claims

0Family size

Assignees

Phio Pharmaceuticals Corp. · US
Biogazelle NV · BE

Inventors

James Cardia · Franklin, US
Karen G. Bulock · Mendon, US
Joke Vandesompele · Zwijnaarde, BE
Gert Van Peer · Zwijnaarde, BE

Key dates

Filing date	Oct 19, 2016
Grant date	Jun 1, 2021
Priority date	—
Expiry date	Oct 19, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/32
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to RNAi constructs with improved cellular uptake characteristics and methods of use of these compounds for silencing expression of long coding RNAs (IncRNAs).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.